More Pharmaceutical Industry Articles

  • Valeant, Ackman make $45.6B Allergan bid

    NEW YORK (AP) — Valeant Pharmaceuticals and activist investor Bill Ackman have unveiled details of their offer to buy Botox maker Allergan, proposing a cash-and-stock deal that could be worth about $45.6 billion. If an acquisition happens, it would give Valeant an array of other cosmetic and...

  • State issues restrictions for painkiller Zohydro

    BOSTON (AP) — After a federal judge struck down Massachusetts' first-of-its-kind ban of the painkiller Zohydro, Gov. Deval Patrick is trying another approach: imposing more requirements on doctors who prescribe the powerful new drug. The governor's office announced late Tuesday that the...

  • Drug firm exec gets 16 months in inside-trade case

    NEWARK, N.J. (AP) — A former pharmaceutical executive has been sentenced to 15 months in prison for his role in an insider trading scheme. John Lazorchak was sentenced Tuesday in federal court in Newark, N.J. He also will have to serve two years of supervised release once he's freed from...

  • FDA panel rejects combination pain pill

    WASHINGTON (AP) — Federal health advisers have unanimously rejected an experimental pain pill that combines two common opioids, oxycodone and morphine. The combination pill, Moxduo, was developed by QRxPharma with the aim of decreasing dangerous side effects of prescription painkillers,...

  • Novartis reshapes business with GSK, Lilly deals

    GENEVA (AP) — Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more restructuring in the fast-changing industry. Joseph...

  • Botox maker Allergan draws bid from Valeant

    NEW YORK (AP) — Valeant Pharmaceuticals is teaming up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to propose a merger with Allergan using a combination of Valeant stock and cash. The...

  • Valeant to bid for Botox maker Allergan

    NEW YORK (AP) — Valeant Pharmaceuticals has teamed up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it intends to propose a merger with Allergan using a combination of Valeant stock and cash. The...

  • Gov. Patrick: Appeal of Zohydro ruling unlikely

    BOSTON (AP) — Gov. Deval Patrick is leaning against any further court action on the state's bid to ban the powerful new painkiller Zohydro in Massachusetts. A federal judge has issued an injunction against the ban, which Patrick ordered after declaring a public health emergency in light of a...

  • Judge blocks Massachusetts ban on painkiller

    BOSTON (AP) — A federal judge has blocked Massachusetts from banning the powerful new painkiller Zohydro. U.S. District Court Judge Rya Zobel on Tuesday issued a preliminary injunction after the maker of the drug, Zogenix, argued in a lawsuit that the ban ordered by Gov. Deval Patrick last...

  • FDA approves injectable diabetes drug from Glaxo

    WASHINGTON (AP) — The Food and Drug Administration said Tuesday it approved a new injectable drug from GlaxoSmithKline plc for adults with Type 2 diabetes. The agency cleared the company's drug, Tanzeum, to help patients control their blood sugar levels, in combination with diet and exercise....

  • FDA OKs Merck tablet to reduce grass allergies

    WHITEHOUSE STATION, N.J. (AP) — Merck & Co. says the Food and Drug Administration has approved its new tablet for grass allergies, Grastek, for patients five to 65 years old. Meant as an alternative to weekly allergy shots, the tablet dissolves under the tongue. Taken daily for a few years,...

  • Report: Glaxo bribed doctors in Poland

    LONDON (AP) — The BBC reports that pharmaceutical company GlaxoSmithKline is accused of bribing doctors to prescribe medicines in Poland. A "Panorama" show to air Monday evening quotes a former sales representative for the company saying doctors there were paid to prescribe its drugs. A...

  • India's Sun Pharma buys Ranbaxy in $4 billion deal

    MUMBAI, India (AP) — India's Sun Pharmaceutical Industries is buying troubled generic drugmaker Ranbaxy Laboratories in a $4 billion deal, the companies said Monday. The combined company will be India's biggest pharmaceutical firm, with annual revenue estimated at $4.2 billion. Sun Pharma...

  • Pfizer reports promising results for cancer drug

    WASHINGTON (AP) — An experimental drug has shown encouraging results in treating advanced breast cancer in an early clinical trial, pharmaceutical giant Pfizer reported Sunday. Pfizer, the world's second largest drugmaker, said the drug prevented breast cancer from worsening for 20.2 months...

  • Trial lawyers helped FDA with rule opening generic drug firms to lawsuits

    The association that represents America's trial lawyers played a special role in the Food and Drug Administration's process of developing a new rule that opens the door to suits against generic drug makers, a potential financial bonanza to lawyers -- and a $4 billion hit to consumers and the...



From the Weekly Standard

  • Kennedy’s Question

    We often think of the Constitution as a two-part document: first the original 1787 text, which primarily establishes the government’s structure; and then the amendments, which primarily set...

    Read More...
  • Mitch McConnell, Judicial Activist

    "This is the best Supreme Court, if you’re interested in a free society and in the ability of Americans to participate in the political process with a minimum amount of government restrictions....

    Read More...
  • Snatching Failure From Victory In Afghanistan

    Media reports suggest that President Obama is looking to declare victory and withdraw from Afghanistan, as he did from Iraq. The military commander in Afghanistan, General Joe Dunford, has said...

    Read More...